Although this study provides compelling evidence that rhein exerts hepatoprotective effects in a HFD-induced NAFLD mouse model by activating the AMPK signaling pathway—promoting ACC phosphorylation and inhibiting SREBP1 expression—several limitations should be noted. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.